Related by context. All words. (Click for frequent words.) 77 CrCl 74 severe renal impairment 74 glomerular filtration rate 73 mL/min/#.# m 2 72 moderate renal impairment 70 creatinine clearance CrCl 70 Hb A1C 70 estimated glomerular filtration 70 mL min 69 BENICAR HCT 69 creatinine ratio 68 serum phosphorus 68 glomerular filtration 68 β blocker 68 insulin detemir 68 #.#mg/dL 68 serum creatinine 68 mEq L 68 serum aminotransferase levels 67 aminotransferases 67 serum potassium 67 aspartate aminotransferase AST 67 serum creatinine levels 67 #mmHg [002] 67 eGFR 67 mm Hg systolic 67 pg mL 67 abacavir lamivudine 67 mmol l 67 serum phosphate 67 serum urate 67 #mg/dL [001] 67 #mmHg [001] 67 lispro 66 hemoglobin A1c levels 66 calculated creatinine clearance 66 QTc 66 PSADT 66 HOMA IR 66 serum sodium 66 mL kg 66 mild renal insufficiency 66 PSA nadir 66 alanine aminotransferase 66 lumbar spine BMD 66 HbA 1c levels 66 urinary albumin 66 baseline HbA1c 66 β blockers 66 elevated serum creatinine 66 mL/min/#.# m2 66 nicardipine 66 irbesartan 66 NPH insulin 66 QTcF 66 severe renal insufficiency 66 Index CDAI 66 mmHg diastolic 66 sUA 66 CK MB 65 HBeAg seroconversion 65 #mg/day [001] 65 QTc interval 65 IELT 65 protein excretion 65 Cmax 65 lopinavir r arm 65 PREZISTA r 65 renal dysfunction 65 CI -#.# 65 NATRECOR R 65 alanine aminotransferase ALT 65 serum magnesium 65 carotid IMT 65 urinary albumin excretion 65 pulmonary artery pressure 65 MADRS score 65 subtrochanteric 65 BENICAR 65 serum phosphorous 65 aminotransferase levels 65 hemoglobin A1c HbA1c 65 ritonavir boosted 65 HbA 1c 65 ng dL 65 Crohn Disease Activity 65 peginterferon alfa 65 postprocedure 65 creatinine levels 65 hyperphenylalaninemia HPA due 65 SGPT 64 serum testosterone 64 systolic BP 64 pulmonary arterial 64 tirofiban 64 corrected QT interval 64 Left Ventricular Ejection Fraction 64 serum uric acid 64 unfractionated heparin 64 renal impairment 64 corticosteroid dose 64 MDRD 64 ug kg 64 mild renal impairment 64 HbA1c levels 64 mcg mL 64 oral antidiabetic medication 64 urine albumin 64 hemoglobin Hb 64 periprocedural 64 candesartan cilexetil 64 morphometric vertebral fractures 64 serum calcium 64 6MWD 64 certolizumab 64 leukopenia 64 tamsulosin 64 nondiabetic patients 64 intima media thickness 64 #mg/dl 64 hypophosphatemia 64 #mg dose [003] 64 atorvastatin #mg 64 LVEF 64 APTIVUS r 64 ARB telmisartan 64 OGTT 64 hypomagnesemia 64 preoperatively 64 ml min 64 adjunctive placebo 64 leukocyte count 64 statin monotherapy 64 Severity MSCS score 64 ATACAND 64 x ULN 64 fasting triglyceride levels 64 lopinavir r 64 μmol L 64 umol L 64 proteinuria 64 per deciliter mg 64 -#.# mg dL [002] 64 mmHg 64 mg/m2 dose 64 oxycodone CR 64 thromboembolic events 64 LEXIVA 64 macroalbuminuria 64 serum phosphate levels 64 tapentadol ER 64 mm Hg diastolic 64 mg dL 63 mmol L 63 VIIBRYD 63 flutamide 63 mmHg systolic 63 mIU L 63 activated partial thromboplastin 63 4mg/kg 63 serum urate levels 63 albumin excretion rate 63 ng mL 63 aspartate aminotransferase 63 glycated hemoglobin levels 63 antihypertensive medications 63 recurrent VTE 63 μg kg 63 hsCRP levels 63 symptomatic VTE 63 g dL 63 hepatic impairment 63 ULORIC 63 pmol L 63 NIHSS score 63 Apidra ® 63 estimated GFR 63 adjunctive ABILIFY 63 intact parathyroid hormone 63 nonfasting triglyceride levels 63 hip BMD 63 albumin excretion 63 Psoriasis Area 63 reduce serum phosphate 63 baseline serum creatinine 63 mcg kg 63 serum calcium levels 63 hours postdose 63 serum PSA 63 thromboembolic complications 63 creatinine 63 severe neutropenia 63 HAQ DI 63 statistical significance p 63 achieved ACR# 63 pulmonary capillary wedge 63 elevated IOP 63 chlorambucil 63 budesonide pMDI 63 NNT = 63 INVEGA ® 63 #mg/day [002] 63 ribavirin therapy 63 endometrial thickness 63 % Confidence Interval 63 extrapyramidal symptoms 63 #.#mmol L [002] 63 NovoLog ® Mix 63 CDAI score 63 #.#mmHg 63 confidence intervals CIs 63 AST ALT 63 8mg/kg 63 benazepril 63 microalbuminuria 63 RLAI 63 fraction LVEF 63 serum potassium levels 62 rizatriptan 62 antihypertensive therapy 62 annualized relapse 62 Expanded Disability Status 62 neutrophil counts 62 serum HBV DNA 62 virologic failure 62 #.#mmol l [002] 62 elevated transaminases 62 mcg QD 62 pretest probability 62 Serum creatinine 62 logistic regression analysis 62 non valvular atrial 62 Index CDAI score 62 #.#/#.# mmHg [001] 62 nmol L 62 transaminases 62 MULTAQ 62 salmeterol fluticasone 62 ACE inhibitor ramipril 62 iPTH 62 ARCOXIA 62 moderate hepatic impairment 62 fluticasone salmeterol 62 transaminase levels 62 generalized edema 62 Primary endpoints 62 thyrotropin levels 62 renal insufficiency 62 ejection fractions 62 serum concentrations 62 IIIa inhibitors 62 Hb levels 62 pyridostigmine 62 ABC/3TC 62 virologic response 62 concomitant medications 62 P = .# 62 Glomerular filtration rate 62 alteplase 62 #mg doses [002] 62 Visual Analogue Scale VAS 62 PRADAXA 62 HbA1C levels 62 creatine kinase MB 62 -#.# ± [002] 62 apnea hypopnea index 62 NIHSS 62 aldosterone antagonist 62 primary hypercholesterolemia 62 steroid dexamethasone 62 mineral density 62 dalteparin 62 systemic corticosteroid 62 transferrin saturation 62 d4T 62 GnRH agonist 62 diastolic BP 62 IIIa inhibitor 62 normal ULN 62 lactate dehydrogenase LDH 62 DAS# [002] 62 HBV DNA levels 62 mg d 62 Renal dysfunction 62 pCR 62 QRS width 62 COMBIVIR 62 urinary calcium 62 glycosylated hemoglobin HbA1c 62 hemoglobin concentrations 62 A1c levels 62 lowest tertile 62 #.#mmol L [001] 62 PEGINTRON TM 62 SCr 62 interferon alfa 2b 62 lipid lowering agents 62 ml kg 62 FEV1 62 μg L 62 elevated ALT 62 nmol liter 62 LANTUS R 62 OADs 62 serum IGF 62 BYSTOLIC 62 asymptomatic carotid stenosis 62 fluvastatin 62 mg QD 62 QTc prolongation 62 ACTOplus met 62 ARIXTRA 62 DEXA scan 62 eplerenone 62 paricalcitol 62 PCWP 62 hypokalemia 62 serum cortisol 62 serum ALT 62 tipranavir r 62 receiving APTIVUS r 62 odds ratios ORs 62 hypercalciuria 62 -#.# log# 62 Kaplan Meier analysis 62 diuretic chlorthalidone 62 Myelosuppression 62 amprenavir 62 thiazide diuretic 61 erythrocyte sedimentation rate 61 levodopa therapy 61 indinavir 61 serum sodium levels 61 highly emetogenic 61 Proteinuria 61 Ejection Fraction 61 #/#mmHg 61 NATRECOR ® 61 glulisine 61 titrated glipizide 61 biphasic insulin aspart 61 mmol L. 61 Scale EDSS 61 cTnT 61 LV ejection fraction 61 serum triglycerides 61 lipid lowering therapy 61 oral glucose tolerance 61 plasma triglycerides 61 systolic dysfunction 61 dosage regimens 61 prospectively stratified 61 #.#g/day 61 interquartile range 61 zonisamide SR 61 mycophenolate mofetil 61 oral antidiabetes 61 left ventricular systolic 61 Lantus ® 61 aPTT 61 tolvaptan 61 glycated hemoglobin 61 Fasting blood glucose 61 acarbose 61 Non inferiority 61 kg m² 61 unfractionated heparin UFH 61 -#.# mmHg 61 #.#/#.# mm Hg [003] 61 LPV r 61 #.#ng/ml 61 FASLODEX 61 prolonged QT interval 61 gastric pH 61 EXJADE 61 chlorthalidone 61 plasma glucose levels 61 overt nephropathy 61 transaminase elevations 61 REYATAZ r arm 61 octreotide LAR 61 primary aldosteronism 61 HER2 expression 61 thiazide diuretics 61 fasting triglycerides 61 rFVIIa 61 serum HCV RNA 61 pioglitazone HCl 61 Acetate Rectal Suppositories 61 infliximab monotherapy 61 stavudine 61 fosamprenavir 61 aspirin clopidogrel 61 timepoint 61 secondary efficacy endpoint 61 postoperative complication 61 g dl 61 MMSE score 61 DULERA 61 achieved statistical significance 61 nondiabetics 61 QTc intervals 61 euvolemic 61 renal function 61 dapagliflozin plus 61 leucopenia 61 GnRH agonists 61 #OHD levels 61 ACTOplus met XR 61 hypogonadal men 61 Montgomery Åsberg Depression 61 fasting plasma glucose FPG 61 hepatorenal syndrome 61 HBeAg negative 61 hypertensives 61 salmeterol fluticasone propionate 61 ADAS cog 61 relapsed MM 61 retinal thickness 61 â ‰ ¥ 61 biochemical recurrence 61 microg 61 binary restenosis 61 hematologic toxicity 61 osteopenic 61 homozygous familial hypercholesterolemia 61 glycated hemoglobin HbA1c 61 receiving INTRON 61 isolated systolic hypertension 61 Peg IFN 61 IXEMPRA 61 Montgomery Asberg Depression 61 desvenlafaxine succinate 61 EDSS score 61 severe exacerbations 61 sUA levels 61 confidence interval CI 61 p = .# [002] 61 serum phosphorus levels 61 cTnI 61 hemoglobin concentration 61 pulmonary exacerbations 61 systolic blood pressures 61 DOXIL 61 highest tertile 61 stable angina 61 thromboprophylaxis 61 atherogenic dyslipidemia 61 pg ml 61 chemoradiation therapy 61 HCTZ 61 DAS# CRP 61 mg dose 61 nephrotoxicity 61 coronary stenosis 60 GFR 60 left ventricular dysfunction 60 hepatic enzyme 60 advanced adenomas 60 ß blockers 60 neurologic progression 60 mU liter 60 ARICEPT 60 lumiracoxib 60 rosuvastatin #mg 60 artery stenosis 60 carbamazepine phenobarbital phenytoin rifampin 60 cGy 60 #ng/ml 60 cytopenias 60 posaconazole 60 pentoxifylline 60 ertapenem 60 PREZISTA rtv 60 left ventricular hypertrophy 60 QT intervals 60 pulmonary exacerbation 60 Thrombolysis 60 #mg BID [003] 60 evaluable subjects 60 systemic embolism 60 Mg Uk 60 malignancy HCM 60 bioavailable testosterone 60 metformin sulfonylurea 60 #mm Hg 60 systemic hypotension 60 infarct size 60 HES CEL 60 LATUDA 60 progression TTP 60 acetazolamide 60 ALT elevation 60 lopinavir ritonavir 60 stavudine d4T 60 serum prostate 60 % CI #.#-#.# [004] 60 pathologic fracture 60 Retreatment 60 FOLPI 60 lumbar spine bone 60 aspirin heparin 60 intraobserver 60 specific antigen PSA 60 glycoprotein IIb IIIa inhibitors 60 arterial thromboembolic events 60 PREMPRO 60 fasting plasma glucose 60 fasting glucose levels 60 HBV infections 60 multivariable adjusted 60 PASI scores 60 TAXOTERE R 60 Coadministration 60 serum ferritin 60 Scale EDSS score 60 L thyroxine 60 angiotensin II receptor blockers 60 PROCRIT 60 dizziness nausea diarrhea 60 attain statistical significance 60 COPD exacerbation 60 pyrazinamide 60 hs CRP 60 bezafibrate 60 mg BID 60 ng dl 60 endarterectomy 60 urinary cortisol 60 NSTE ACS 60 TEAEs 60 carotid endarterectomy CEA 60 Oral corticosteroids 60 triglyceride concentrations 60 gout flares 60 oxycodone IR 60 postprandial glucose 60 oxygen desaturation 60 mm Hg 60 endometrial hyperplasia 60 PRADAXA #mg 60 IFN alfa 60 antiretroviral naive 60 SUVmax 60 ribavirin USP 60 definite stent thrombosis 60 mineral density BMD 60 colesevelam HCl 60 thiazides 60 serum estradiol 60 plasma urate 60 bolus dose 60 poor metabolizers 60 methotrexate monotherapy 60 #μg [001] 60 subclinical hyperthyroidism 60 metabolite concentrations 60 inhaled budesonide 60 oral prednisolone 60 nadolol 60 LMWH 60 urinary oxalate 60 lacosamide 60 orthostatic hypotension 60 mucosal healing 60 idraparinux 60 atazanavir 60 LEXIVA r 60 CK # plasma concentrations 60 log# IU mL 60 hepatic enzymes 60 mg tid 60 cilostazol 60 International Normalized Ratio 60 reinfarction 60 urate lowering therapy 60 detrusor overactivity 60 plasma concentrations 60 MMSE scores 60 cells mcL 60 spirometric 60 Navelbine 60 lymphocyte count 60 FOLFOX6 60 chest radiographs 60 Perforomist Inhalation Solution 60 CDAI 60 asthma exacerbation 60 deep venous thromboses 60 serum sodium concentration 60 Response Evaluation Criteria 60 tenofovir emtricitabine 60 candesartan 60 noninferiority 60 IU ml 60 nonvertebral fracture 60 QRS duration 60 VELCADE melphalan 60 Zometa hazard 60 detemir 60 cerebrovascular events 60 EURIDIS 60 albumin creatinine ratio 60 carotid artery intima media 60 Pain Intensity 60 urinary N telopeptide 60 -#.# mg dL [001] 60 liver transaminases 60 confidence interval #.#-#.# 60 plasma creatinine 60 lanthanum carbonate 60 PREZISTA ritonavir 60 mg orally 60 thrombolytic therapy 60 LVSD 60 HPA axis suppression 60 nonfatal MI 60 sotalol 60 postmenopausal osteoporotic women 60 PREZISTA r arm 60 nevirapine Viramune 60 Hypotension 60 Mean Symptom Complex 60 HbA1C 60 sinus tachycardia 60 Welchol 60 mg BID dose 59 intravesical therapy 59 CI #.#-#.# [001] 59 HIV RNA 59 min -1 59 elevated LDH 59 PROCTOCORT ® Suppository Hydrocortisone 59 hypercalcemia 59 fasting blood glucose 59 undetectable HBV DNA 59 serum testosterone levels 59 dopaminergic therapy 59 graft occlusion 59 log# copies mL 59 mg TID 59 Hb A1c 59 pericardial effusion 59 thrombocytosis 59 % CI #.#-#.# [006] 59 cardiac troponin T 59 D dimer 59 loop diuretics 59 Postoperative complications 59 concentration Cmax 59 beta blocker therapy 59 dose colchicine 59 baseline FEV1 59 luminal diameter 59 cTnT levels 59 serum PTH 59 AUC0 59 troponin T 59 anemia hemoglobin 59 nonvertebral fractures 59 noninferior 59 postintervention 59 detectable HCV RNA 59 thyroid stimulating hormone 59 Tasigna prolongs 59 mg qd 59 5-FU/LV 59 unresectable HCC 59 mIU ml 59 myocardial infarction stroke 59 HbA1c 59 Insulin sensitivity 59 LV dysfunction 59 Creatinine 59 Peginterferon Alfa 2a 59 ipsilateral stroke 59 perioperatively 59 hemorrhagic complications 59 Rating Scale MADRS 59 XIENCE V PROMUS Stent 59 Ranolazine 59 amoxicillin clavulanate 59 SGOT 59 postdose 59 EDSS scores 59 milliliters mL 59 intracranial hemorrhage ICH 59 T2DM 59 peginterferon alfa 2a 59 mg dl 59 intravitreal injections 59 postoperative mortality 59 AVODART 59 hemodynamically significant 59 EBRT 59 Score TOS 59 Pioglitazone 59 Pharmacokinetic parameters 59 FOLFOX4 59 % CI #.#-#.# [003] 59 ischemic cardiomyopathy 59 bone marrow reticulin deposition 59 MDRD equation 59 abciximab 59 virological response 59 mCi 59 echocardiographic parameters 59 plus prednisone 59 carotid stenosis 59 flecainide 59 everolimus eluting stents 59 IPSS 59 atazanavir ritonavir 59 trimethoprim sulfamethoxazole 59 systolic diastolic blood 59 glargine 59 danazol 59 hypopneas 59 glycemia 59 composite endpoint 59 residual platelet reactivity 59 ACTEMRA TM 59 HBeAg negative patients 59 See CONTRAINDICATIONS 59 xanthine oxidase inhibitor 59 test OGTT 59 immunosuppressive regimen 59 aldosterone antagonists 59 liver histology 59 IOP lowering 59 ALND 59 neostigmine 59 ng ml 59 abdominal adiposity 59 baseline LDH 59 azacitidine 59 recurrent ischemia 59 systolic pressure 59 tibolone 59 mcg BID 59 reflux symptoms 59 Skin sterol 59 elevated triglyceride levels 59 Secondary endpoints 59 thromboembolic 59 #mg dose [001] 59 #mg #mg #mg [003] 59 lipid elevations 59 sinus rhythm 59 Y BOCS 59 plasma glucose 59 TDF FTC 59 TLUS 59 AUCs 59 coadministration 59 Mg Usa 59 milrinone 59 systemic corticosteroids 59 dobutamine 59 urinary protein 59 placebo p = 59 receiving prophylactic anticoagulation 59 laboratory abnormalities 59 ADCS CGIC 59 Tipranavir 59 PaO 2 59 aminotransferase elevations greater 59 platelet reactivity 59 AVANDIA 59 biochemical relapse 59 adenoma recurrence 59 atheroma volume 59 Solid Tumors criteria 59 steatosis 59 NYHA Class II 59 subclinical hypothyroidism 59 serum leptin 59 lipoprotein levels 59 salmeterol inhalation powder 59 hypogonadal 59 complete cytogenetic response 59 Alzheimer Disease Assessment 59 BMI ≥ 59 posttransplant 59 CTEPH 59 MELD scores 59 oxcarbazepine 59 hypervolemic hyponatremia 59 mean baseline HbA1c 59 NYHA functional class 59 pneumonectomy 59 Naive Patients 59 undetectable HCV RNA 59 low dose Iluvien 59 K ras mutations 59 tranylcypromine 59 clopidogrel Plavix 59 simvastatin #mg 59 lactate dehydrogenase 59 cerebral perfusion 59 triglyceride concentration 59 CIN3 59 cerebral oxygenation 59 serum glucose 59 quinidine 59 -#.# log# copies mL 59 plus methotrexate 59 Scale cognitive subscale 59 placebo dexamethasone 59 mU L 59 severe hepatic insufficiency 59 ZYVOX 59 CCyR 59 prolactin levels 59 lamivudine refractory patients 59 terfenadine 59 prednisone prednisolone 59 peak VO2 59 ursodeoxycholic acid 59 lipid parameters 59 Microalbuminuria 59 serum albumin 59 Ishak fibrosis score 59 μg liter 59 thickness IMT 59 clomipramine 59 Victoza R 59 metabolic parameters 59 hypercholesterolaemia 59 potassium sparing diuretics 59 Hemoglobin A1c 59 elevated LDL cholesterol 59 intraclass correlation coefficient 59 preserved ejection fraction 59 colorectal adenoma 59 foveal thickness 59 hematological parameters 59 Viread Emtriva 59 bronchial hyperresponsiveness 59 HIV HCV coinfected 59 treat NNT 59 headache nasopharyngitis 59 asymptomatic hyperuricemia 59 Heavy menstrual bleeding 59 recurrent glioblastoma multiforme 59 Plasma concentrations 59 platelet inhibition 59 pT3 59 tolterodine ER 59 subcutaneous enoxaparin 59 homocysteine concentrations 59 urinary sodium excretion 59 contrast induced nephropathy 59 DLTs 59 SIMCOR 59 COPEGUS 59 fluid overload 59 #mg/dL [002] 59 CLINICAL STUDIES 59 IU mL 59 del 5q MDS 59 Endothelial dysfunction 58 endoscopic gastric ulcers 58 lymphocytosis 58 neutropenia dehydration dyspnea 58 serum triglyceride levels 58 stenoses 58 zolmitriptan 58 Pegasys ® 58 potent CYP#A# inhibitors 58 intima media thickness IMT 58 clinically meaningful improvement 58 perioperative mortality 58 aminotransferase ALT 58 WOMAC pain 58 glimepiride 58 mg eq 58 carotid intima media 58 colorectal liver metastases 58 timepoints 58 crossclamp 58 genotypic resistance 58 daunorubicin 58 serum retinol 58 primidone 58 subscore 58 #-#,# mg 58 fondaparinux 58 nonoperative treatment 58 RECIST Response Evaluation Criteria 58 apolipoprotein B 58 mcg kg REBETOL 58 transthoracic 58 preoperative chemotherapy 58 alfa 2a 58 arteriolar 58 transaminase 58 Femara letrozole 58 hemoglobin A1C 58 pharmacologically active isomer 58 BARACLUDE ® 58 normothermic 58 abdominal circumference 58 #mg BID [001] 58 transurethral resection 58 serum transaminases 58 electrolyte abnormalities 58 peginterferon alfa 2b 58 8mg 58 Platelet counts 58 ASCUS 58 neurodevelopmental impairment 58 oral prednisone 58 statistically significant p = 58 univariate 58 NYHA Class III 58 comparator arm 58 Brief Psychiatric 58 1c HbA 1c 58 myocardial viability 58 hypocalcemia 58 TWYNSTA 58 fasting insulin 58 atherothrombotic events 58 multivariate Cox 58 oral hypoglycemic agents 58 repeat paracentesis 58 Telithromycin 58 solifenacin 58 interferon alfa 58 q#h 58 FOSRENOL ® 58 6mg 58 cinacalcet 58 oral anticoagulation 58 diastolic pressures 58 radiotherapy RT 58 NIH CPSI 58 Hemolysis 58 corneal thickness 58 mL sec 58 radical nephrectomy 58 metastatic malignant 58 serum LDL cholesterol 58 Castration Resistant Prostate Cancer 58 intravaginal ejaculatory latency 58 RAPAFLO R 58 mg/m2/day 58 antibody titer 58 Drill composites 58 Nesiritide 58 euthyroid 58 symptomatic carotid stenosis 58 Ramipril 58 atrioventricular block 58 selegiline 58 Unified Parkinson Disease 58 advanced adenoma 58 elevated creatinine 58 CVD mortality 58 placebo p 58 Doxil ® 58 adefovir treated 58 weekly CSBMs 58 blood Phe 58 doxorubicin cyclophosphamide 58 drug eluting stent implantation 58 mmol 58 AVELOX 58 International Prostate Symptom 58 TURBT 58 hypoglycemic events 58 Postoperatively 58 salivary flow 58 kg -1 58 spontaneous bowel movements 58 mcg dose 58 mm3 58 pravastatin Pravachol 58 d amphetamine 58 macrovascular events 58 urate levels 58 Hazard Ratio HR 58 fluvastatin Lescol 58 Secondary efficacy endpoints 58 + PH# 58 prospectively defined 58 Elitek 58 elevated intraocular pressure 58 = #.#-#.# 58 thickness CIMT 58 strontium ranelate 58 baseline Hb 58 Hydrochlorothiazide 58 State Examination MMSE 58 plus prednisone prednisolone 58 corneal curvature 58 QVAR R 58 Pred Forte